Latest News

Liver mesenchymal stromal cells could be a better option for many therapeutic applications




Mesenchymal stromal cells from fat tissue and bone marrow are widely used in therapeutic trials for their anti-inflammatory qualities, but new Mayo Clinic research finds that liver cells may be of greater value.

Source link




Related posts

Multiresistant intestinal bacteria spread widely in Vietnamese hospitals

Newsemia

FDA approves effective new treatment for extremely drug-resistant tuberculosis

Newsemia

Growth to early adulthood following extremely preterm birth: the EPICure study

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy